Literature DB >> 11250896

Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells.

D Braaten1, J Luban.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) Gag polyprotein binds most members of the cyclophilin family of peptidyl-prolyl isomerases. Of 15 known human cyclophilins, cyclophilin A (CypA) has been the focus of investigation because it was detected in HIV-1 virions. To determine whether CypA promotes HIV-1 replication, we deleted the gene encoding CypA (PPIA) in human CD4(+) T cells by homologous recombination. HIV-1 replication in PPIA(-/-) cells was decreased and not inhibited further by cyclosporin or gag mutations that disrupt Gag's interaction with cyclophilins, indicating that no other cyclophilin family members promote HIV-1 replication. The defective replication phenotype was specific for wild-type HIV-1 since HIV-2/SIV isolates, as well as HIV-1 bearing a gag mutation that confers cyclosporin resistance, replicated the same in PPIA(+/+) and PPIA(-/-) cells. Stable re-expression of CypA in PPIA(-/-) cells restored HIV-1 replication to an extent that correlated with steady-state levels of CypA. Finally, virions from PPIA(-/-) cells possessed no obvious biochemical abnormalities but were less infectious than virions from wild-type cells. These data formally demonstrate that CypA regulates the infectivity of HIV-1 virions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11250896      PMCID: PMC145517          DOI: 10.1093/emboj/20.6.1300

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  69 in total

1.  A single Trp121 to Ala121 mutation in human cyclophilin alters cyclosporin A affinity and peptidyl-prolyl isomerase activity.

Authors:  M J Bossard; P L Koser; M Brandt; D J Bergsma; M A Levy
Journal:  Biochem Biophys Res Commun       Date:  1991-05-15       Impact factor: 3.575

Review 2.  HIV-1 gag proteins: diverse functions in the virus life cycle.

Authors:  E O Freed
Journal:  Virology       Date:  1998-11-10       Impact factor: 3.616

3.  Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein.

Authors:  T Wilk; B Gowen; S D Fuller
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

4.  Characterization of the human cyclophilin gene and of related processed pseudogenes.

Authors:  B Haendler; E Hofer
Journal:  Eur J Biochem       Date:  1990-07-05

5.  Peptidyl-prolyl cis-trans-isomerase from Escherichia coli: a periplasmic homolog of cyclophilin that is not inhibited by cyclosporin A.

Authors:  J Liu; C T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Human and Escherichia coli cyclophilins: sensitivity to inhibition by the immunosuppressant cyclosporin A correlates with a specific tryptophan residue.

Authors:  J Liu; C M Chen; C T Walsh
Journal:  Biochemistry       Date:  1991-03-05       Impact factor: 3.162

7.  Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.

Authors:  A Mörner; A Björndal; J Albert; V N Kewalramani; D R Littman; R Inoue; R Thorstensson; E M Fenyö; E Björling
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  HEED, the product of the human homolog of the murine eed gene, binds to the matrix protein of HIV-1.

Authors:  R Peytavi; S S Hong; B Gay; A D d'Angeac; L Selig; S Bénichou; R Benarous; P Boulanger
Journal:  J Biol Chem       Date:  1999-01-15       Impact factor: 5.157

9.  Cyclophilin a modulates processing of human immunodeficiency virus type 1 p55Gag: mechanism for antiviral effects of cyclosporin A.

Authors:  D N Streblow; M Kitabwalla; M Malkovsky; C D Pauza
Journal:  Virology       Date:  1998-06-05       Impact factor: 3.616

10.  Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14.

Authors:  S Dewhurst; J E Embretson; D C Anderson; J I Mullins; P N Fultz
Journal:  Nature       Date:  1990-06-14       Impact factor: 49.962

View more
  136 in total

Review 1.  Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection.

Authors:  Jeremy Luban
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

2.  A structural biology approach enables the development of antimicrobials targeting bacterial immunophilins.

Authors:  Darren W Begley; David Fox; Dominic Jenner; Christina Juli; Phillip G Pierce; Jan Abendroth; Muigai Muruthi; Kris Safford; Vanessa Anderson; Kateri Atkins; Steve R Barnes; Spencer O Moen; Amy C Raymond; Robin Stacy; Peter J Myler; Bart L Staker; Nicholas J Harmer; Isobel H Norville; Ulrike Holzgrabe; Mitali Sarkar-Tyson; Thomas E Edwards; Donald D Lorimer
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

3.  Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes.

Authors:  Joan P Breyer; Kate M McReynolds; Brian L Yaspan; Kevin M Bradley; William D Dupont; Jeffrey R Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

4.  The Tec family kinase Itk exists as a folded monomer in vivo.

Authors:  Qian Qi; Avery August
Journal:  J Biol Chem       Date:  2009-08-28       Impact factor: 5.157

5.  Non-cleavage site gag mutations in amprenavir-resistant human immunodeficiency virus type 1 (HIV-1) predispose HIV-1 to rapid acquisition of amprenavir resistance but delay development of resistance to other protease inhibitors.

Authors:  Manabu Aoki; David J Venzon; Yasuhiro Koh; Hiromi Aoki-Ogata; Toshikazu Miyakawa; Kazuhisa Yoshimura; Kenji Maeda; Hiroaki Mitsuya
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

6.  Analysis of human cell heterokaryons demonstrates that target cell restriction of cyclosporine-resistant human immunodeficiency virus type 1 mutants is genetically dominant.

Authors:  Chisu Song; Christopher Aiken
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

7.  Cyclophilin A peptidyl-prolyl isomerase activity promotes ZPR1 nuclear export.

Authors:  Husam Ansari; Giampaolo Greco; Jeremy Luban
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

8.  Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infection.

Authors:  Xiaochen Tian; Chao Zhao; Hongguang Zhu; Weimin She; Jiming Zhang; Jing Liu; Lanjuan Li; Shusen Zheng; Yu-Mei Wen; Youhua Xie
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

9.  Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A.

Authors:  Songkai Liu; Maria Asparuhova; Vincent Brondani; Ingrid Ziekau; Thomas Klimkait; Daniel Schümperli
Journal:  Nucleic Acids Res       Date:  2004-07-14       Impact factor: 16.971

10.  Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro.

Authors:  Feng Yang; Jason M Robotham; Heather B Nelson; Andre Irsigler; Rachael Kenworthy; Hengli Tang
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.